Research shows vision sensitivity tests may identify dementia 12 years before diagnosis, offering hope for intervention and ...
For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...
Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
Scientists report long-term gantenerumab use might prevent cognitive decline in people with genetic predisposition to ...
An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...
The inherited genetic mutations cause the buildup of plaque in the brain and all but guarantees ... the risk of a side effect known as amyloid-related imaging abnormalities (ARIA), which in ...
Tests show that her brain and ... they were able to remove more amyloid from the brain. But other biomarker data is less clear. PET imaging scans, for example, didn’t show much of a difference ...
Tests show that her brain and ... they were able to remove more amyloid from the brain. But other biomarker data is less clear. PET imaging scans, for example, didn’t show much of a difference ...